Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +36.41%
#3 Cysic Cysic +25.00%
#4 Velvet Velvet +21.00%
#5 Fabric Protocol Fabric Protocol +18.27%
#6 Bedrock Bedrock +17.29%
#7 Nillion Nillion +16.73%
#8 Nockchain Nockchain +14.69%
#9 Perle Perle +12.86%
#10 Versatize Coin Versatize Coin +12.49%
Coin of the day
EXOD EXOD
設定
言語
日本
通貨
USD
テーマ
Peak Bio, Inc. Peak Bio, Inc.

Peak Bio, Inc.

PKBO
株式のランク #37553
Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical... Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical development phase, committed to devising treatments for critical, unmet medical needs in the realms of oncology and inflammatory disorders. The company harnesses its unique, proprietary toxin—known as PH-1 or Thailanstatin—a spliceosome modulator, to create its inaugural range of innovative Antibody-Drug Conjugate (ADC) therapies designed for cancer patients facing significant challenges. Additionally, Peak Bio's leading investigational drug, PHP-303, a small molecule, is on the verge of commencing a Phase II dose clinical trial for the rare condition Alpha1 anti-trypsin deficiency (AATD). The company's operations are situated in Palo Alto, California.
株価
$0.07
最終同期: 2024-11-12
時価総額
$1.62M
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Peak Bio, Inc. (PKBO)

カテゴリー

Healthcare
Peak Bio, Inc.（PKBO）の株式分割履歴
Peak Bio, Inc.株（シンボル：PKBO）は合計で0回の株式分割を実施しました。
最新の株式分割はAug 15, 2026に行われました。
Aug 15, 2026より前に購入されたPKBO株は、現在0PKBO株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE